Hallman M, Gluck L
Biochim Biophys Acta. 1975 Nov 21;409(2):172-91. doi: 10.1016/0005-2760(75)90152-6.
Lamellar inclusion bodies, apparent precursors for alveolar surfactant lining, have remarkably similar phospholipid composition to surfactant from alveolar lavage, but distinctly different from other fractions studied: mitochondria, microsomal fraction containing endoplasmic reticulum membranes, plasma membranes and nuclei. Surfactant contained (as % of total phospholipid phosphate): 75.5-77.0% lecithin, 11.0-11.2% phosphatidylglycerol, 4.2-4.6% phosphatidylethanolamine, 3.0-3.2% phosphatidylinositol, 1.5-1.7% bis-(monoacylglycerol) phosphate, 1.2-1.9% phosphatidylserine, and 0.7-1.5% sphingomyelin. Fatty acids of phosphatidylglycerol from lamellar bodies were similar to those from microsomes but different from those in mitochondria. Lung homogenate in continuous sucrose density gradient displayed two major activity peaks of phosphatidylglycerol synthesis: the heavier from mitochondria; the lighter from endoplasmic reticulum. Studies on mechanism of phosphatidylglycerol synthesis in vitro revealed (in these two fractions) CDP-diglyceride and sn-glycerol phosphate precursors to phosphatidylglycerol phosphate, that hydrolysed to phosphatidylglycerol. In microsomes disaturated CDP-diglycerides were 1.6-1.9 times more active substrates than in mitochondria, whereas CDP-diglycerides from egg lecithin were almost equally active. In contrast to lung mitochondria no cardiolipin synthesis was detected in microsomes. The highest specific activities for phosphatidate cytidyltransferase, CDP-diglyceride-inositol phosphatidyltransferase, choline phosphotransferase, and phosphatidylethanolamine methyltransferase were all found in microsomes. The present in vitro studies and additional evidence (M. Hallman and L. Gluck, (1975) Fed. Proc. 34, 274) support the hypothesis that de novo synthesis of surfactant lecithin phosphatidylinositol and phosphatidylglycerol takes place in the endoplasmic reticulum of alveolar cells.
板层小体是肺泡表面活性物质内衬的明显前体,其磷脂组成与肺泡灌洗中的表面活性物质非常相似,但与其他研究的组分明显不同:线粒体、含有内质网膜的微粒体组分、质膜和细胞核。表面活性物质含有的(占总磷脂磷酸的百分比):卵磷脂75.5 - 77.0%、磷脂酰甘油11.0 - 11.2%、磷脂酰乙醇胺4.2 - 4.6%、磷脂酰肌醇3.0 - 3.2%、双(单酰甘油)磷酸1.5 - 1.7%、磷脂酰丝氨酸1.2 - 1.9%和鞘磷脂0.7 - 1.5%。板层小体中磷脂酰甘油的脂肪酸与微粒体中的相似,但与线粒体中的不同。在连续蔗糖密度梯度中的肺匀浆显示出磷脂酰甘油合成的两个主要活性峰:较重的来自线粒体;较轻的来自内质网。体外磷脂酰甘油合成机制的研究表明(在这两个组分中),CDP - 二甘油酯和sn - 甘油磷酸是磷脂酰甘油磷酸的前体,后者水解为磷脂酰甘油。在微粒体中,二饱和CDP - 二甘油酯作为底物的活性比线粒体中的高1.6 - 1.9倍,而来自卵磷脂的CDP - 二甘油酯活性几乎相同。与肺线粒体相反,在微粒体中未检测到心磷脂合成。磷脂酸胞苷转移酶、CDP - 二甘油酯 - 肌醇磷脂酰转移酶、胆碱磷酸转移酶和磷脂酰乙醇胺甲基转移酶的最高比活性均在微粒体中发现。目前的体外研究及其他证据(M. 哈尔曼和L. 格鲁克,(1975年)《联邦会议录》34卷,274页)支持表面活性物质卵磷脂、磷脂酰肌醇和磷脂酰甘油的从头合成发生在肺泡细胞内质网中的假说。